L-K6L9, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ470)
Product Quick View
L-K6L9 shows antimicrobial and antibiofilm activities against P. aeruginosa from cystic fibrosis patients. L-K6L9 is stable and resistant to degradation by cystic fibrosis sputum proteases and will not induce bacterial resistance .
| Overview | |
|---|---|
| Synonyms | L-K6L9; L-K6L9 peptide |
| Source | Synthetic |
| Sequence | Leu-Lys-Leu-Leu-Lys-Lys-Leu-Leu-Lys-Lys-Leu-Leu-Lys-Leu-Leu-NH2 |
| Sequence Shortening | LKLLKKLLKKLLKLL-NH2 |
| Activity | Gram-positive bacteria; Gram-negative bacteria; Fungi; Virus; Cancer cells; Apoptosis; Mitochondria |
| Physical State | Powder |
| Purity | >98% |
| Storage | The power can be stored at 4°C for 2 years or at -20°C for 3 years. |
For Research Use Only.
Related products
- K11 peptide, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ190)
- Brevinin-1Ea, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ315)
- Porcine β-defensin 103 isoform X1 TFA, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ288)
- Influenza A virus-IN-8, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ133)
- Seabream hepcidin, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ601)
- Pilosulin-1(86-112), Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ569)
- FGF basic (1-24), Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ60)
- ALA-A2 peptide, Antimicrobial Peptide (AMP) (CAT#: BMWJ-0826-WJ253)
Online Inquiry